LRA's 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development
Read more ➡Mild COVID-19 disease may trigger long-term immunity
Read more ➡Benaroya Research Institute president pulls back the curtain on Covid-19 study
Read more ➡Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses
Read more ➡
Science in Seattle: Targeting the Genetic Roots of Autoimmunity
Early introduction of gluten may prevent celiac disease in children
Read MoreThu “Kim” Le interns with Benaroya Research Institute, doing cancer research from home
Read more ➡
‘Lost time and momentum’
Benaroya Research Institute at Virginia Mason Collaborates to Discover Genes that Block Viral Entry of Ebola and SARS Coronaviruses
Read More
Geekwire: Researchers discover new avenue for fighting COVID-19, Ebola and other viral diseases
Read More
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
Read MoreNew biotech startup GentiBio lands $20M, inks licensing deals with Seattle Children’s and BRI
Read more ➡
GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology
Read More
Dr. Carmen Mikacenic Joins Benaroya Research Institute at Virginia Mason
Read More
